Cortisol Is a Dynamic Signal, Not a Diagnosis

Cortisol has become one of the most overused explanatory variables in online health culture. It is blamed for abdominal fat, insomnia, fatigue, anxiety, cravings, inflammation and difficulty losing weight. A parallel market offers “cortisol resets”, adrenal-support supplements and symptom lists that supposedly identify hormonal imbalance without formal testing.

The underlying hormone is not fictional.

Cortisol is essential to normal physiology. It participates in glucose regulation, vascular function, immune signalling, cognition, sleep-wake organisation and adaptation to stress. Pathological glucocorticoid excess can cause serious disease. Inadequate glucocorticoid activity can also be dangerous.

That alone should make the simplistic model suspicious.

The goal of a healthy endocrine system is not the lowest possible cortisol concentration. It is appropriate regulation across time and tissue.

Cortisol is rhythmic by design

Healthy cortisol secretion is strongly circadian and also pulsatile.

In people with a conventional sleep-wake schedule, concentrations rise toward the active phase, are relatively high around awakening and decline across the day toward a night-time nadir. Superimposed on that daily rhythm are ultradian pulses.

The cortisol awakening response adds another layer: cortisol typically rises rapidly after waking.

That rise is not evidence of pathology. It is part of normal endocrine organisation.

This is why interpreting cortisol without time is inherently problematic. The same numerical concentration can be expected in the morning and abnormal late at night.

A random value therefore does not describe a person's entire HPA-axis state.

The temporal structure is part of the biology.

Stress does not mean cortisol is constantly high

The phrase “stress raises cortisol” is directionally useful for acute physiology and misleading when extended into a universal chronic model.

Chronic stress can alter HPA-axis regulation, but the pattern is not always a sustained upward shift. Studies report exaggerated responses in some contexts, blunted responses in others, flatter diurnal rhythms and altered awakening responses.

The system can become dysregulated without cortisol being uniformly high at every time point.

This matters because social-media diagnosis often assumes one scalar quantity called “stress cortisol”. Real HPA-axis biology is a dynamic process involving feedback, timing, receptor sensitivity and tissue-specific metabolism.

A person can experience high subjective stress without persistently elevated cortisol. Another can show altered rhythmicity without describing extreme stress.

Stress and cortisol overlap. They are not synonyms.

Cushing syndrome is real; “cortisol belly” is not a diagnosis

The association between glucocorticoids and body-fat distribution is one reason online cortisol narratives feel plausible.

Cushing syndrome, which involves excessive glucocorticoid exposure, can cause central adiposity together with muscle weakness, hypertension, glucose intolerance, skin changes, bone disease and other characteristic features.

That is established endocrinology.

It does not follow that ordinary abdominal fat is a visual marker of high cortisol.

Obesity is common. Cushing syndrome is not.

The Endocrine Society therefore recommends targeted testing in people with features that raise clinical suspicion rather than indiscriminate screening of everyone with obesity, depression or fatigue.

This is an important base-rate issue. A symptom can occur in a rare endocrine disorder while being far more commonly caused by other conditions.

Abdominal shape alone cannot identify the HPA axis.

The obesity-cortisol relationship is heterogeneous

A systematic review of cortisol activity in obesity found inconsistent results across studies.

Some reported increased HPA-axis reactivity, others reduced responses. Associations differed by sex, type of obesity, tissue, measurement method and stress context.

Local glucocorticoid metabolism also matters. Enzymes such as 11β-HSD1 can regenerate active cortisol within tissues, meaning adipose exposure can differ from what a single circulating measurement suggests.

This is one reason the phrase “high cortisol causes belly fat” is too simple.

The relationship is bidirectional and context-dependent. Adiposity, sleep, stress, insulin sensitivity and local tissue metabolism can all interact with glucocorticoid signalling.

A photograph cannot resolve that system.

Random cortisol testing is usually the wrong question

Because cortisol varies strongly over time, endocrine testing for pathological excess uses methods designed around specific physiological properties.

The Endocrine Society recommends tests such as late-night salivary cortisol, 24-hour urinary free cortisol or dexamethasone suppression testing in appropriate clinical contexts. It recommends against random serum cortisol as a screening test for Cushing syndrome.

This is not bureaucratic complexity.

It reflects the fact that one sample may capture a normal pulse, a morning peak, acute stress or medication effects.

A home test or isolated blood result becomes easy to overinterpret when the reference process itself is dynamic.

Measurement without an appropriate model can create more certainty than information.

Adrenal fatigue is not established endocrinology

The idea of adrenal fatigue proposes that prolonged stress exhausts the adrenal glands, eventually producing low cortisol and a characteristic collection of symptoms.

The symptoms are usually broad: tiredness, poor concentration, sleep disturbance, cravings and difficulty coping with stress.

Those symptoms are real.

The proposed syndrome is not well supported.

A systematic review examining the adrenal-fatigue literature found inconsistent methods and no convincing evidence establishing it as a distinct medical condition. The Endocrine Society likewise states that adrenal fatigue is not a recognised diagnosis.

This distinction matters because adrenal insufficiency is real.

Primary or secondary adrenal insufficiency can be serious and has established diagnostic pathways. Vague wellness diagnoses risk confusing non-specific symptoms with a condition that requires proper endocrine assessment.

Rejecting adrenal fatigue is not rejecting patients' symptoms. It is rejecting an unvalidated causal explanation for them.

“Lower cortisol” is not automatically a therapeutic objective

Once cortisol is framed as harmful, any intervention that lowers it can be marketed as beneficial.

That reasoning is incomplete.

A biomarker change is not automatically a health outcome.

An intervention that modestly lowers a cortisol measurement may alter subjective stress, or it may change only one assay under one condition. The clinical meaning depends on the population, timing and outcome of interest.

This is especially important because normal cortisol is necessary. Suppressing it below appropriate levels would not represent improved health.

The target is regulated glucocorticoid signalling, not minimal glucocorticoid signalling.

Ashwagandha illustrates the difference between a signal and a cure

Ashwagandha is frequently marketed as a cortisol-lowering adaptogen.

Recent meta-analyses have reported modest reductions in cortisol and some stress-related measures in selected populations. That is a legitimate research signal.

It does not establish that ashwagandha “fixes high cortisol”, nor that people with vague symptoms have a cortisol disorder that should be treated with a supplement.

The studies vary in dose, formulation, duration and participant characteristics. Effects on perceived stress are not always consistent even when cortisol changes.

The scientifically appropriate conclusion is therefore conditional: some preparations may influence stress-related outcomes in some populations.

That is very different from a universal endocrine treatment.

Adrenal-support supplements raise a separate concern

A small Mayo Clinic study purchased over-the-counter supplements marketed for adrenal support and chemically analysed their contents.

The researchers detected thyroid hormone in all products tested and one or more steroid-related hormones in most.

The study was limited to a small sample and does not imply that every adrenal-support product contains undeclared hormones.

It does demonstrate why products marketed as “balancing” endocrine systems should not automatically be assumed benign.

A supplement can alter the very hormonal environment it claims to normalise.

Cortisol does not invalidate energy balance

Another common claim is that cortisol prevents weight loss even when someone is “in a calorie deficit”.

Stress can absolutely influence weight regulation. It can alter appetite, sleep, food preference, activity and adherence. Glucocorticoids also affect glucose and fat metabolism.

But cortisol does not create energy from nothing.

The practical issue is that intended energy intake and actual long-term energy balance can diverge under stress. Sleep deprivation can affect appetite. Stress can change snacking. Activity may fall. Fluid balance can shift.

The useful model is therefore behavioural and physiological, not magical: stress can change several components of energy balance and body composition.

That is more complex than “cortisol blocks fat loss”, but it is also more defensible.

Cortisol and inflammation are not a simple one-way relationship

Another online simplification claims that cortisol itself “causes inflammation”.

Glucocorticoids are among the most important anti-inflammatory signalling molecules in human physiology, and synthetic glucocorticoids are used therapeutically to suppress immune responses.

At the same time, chronic stress can alter immune regulation and glucocorticoid sensitivity. Tissue-specific effects and receptor adaptation complicate the relationship further.

So the correct model is not “cortisol equals inflammation”.

It is a dynamic interaction between stress systems and immune systems.

Reducing that interaction to one arrow creates exactly the kind of explanatory confidence that social media rewards and endocrinology resists.

The common symptom list is not a diagnostic instrument

The broad appeal of cortisol content comes from symptom lists that are highly relatable.

Poor sleep, fatigue, anxiety, cravings, irritability and abdominal fat are common.

That makes them poor discriminators for a specific endocrine disorder.

If a symptom occurs in many conditions, seeing the symptom does not strongly identify one cause.

This is why diagnosis cannot proceed by matching oneself to a graphic containing common experiences.

The more universal the symptom list, the less specific the inference.

Conclusion

Cortisol is not a toxin and not a diagnosis.

It is a dynamic hormone with circadian and ultradian organisation, tissue-specific effects and essential physiological functions. Pathological cortisol excess exists and can cause serious disease. Chronic stress can influence HPA-axis regulation and metabolic health.

Those facts do not validate “high cortisol” as a universal explanation for belly fat, fatigue, insomnia and anxiety.

Random cortisol values are difficult to interpret. Adrenal fatigue is not an established endocrine diagnosis. Lowering cortisol is not automatically beneficial.

The most accurate summary is simple: cortisol is a regulated signal, and its meaning depends on timing, context and clinical state.

That is less satisfying than a single villain.

It is also much closer to endocrine physiology.

---

References

1. Clarke SA, Eng PC, Comninos AN, et al. Current Challenges and Future Directions in the Assessment of Glucocorticoid Status. Endocrine Reviews. 2024;45:795–817. https://academic.oup.com/edrv/article/45/6/795/7682328

2. Stalder T, Oster H, Abelson JL, et al. Cortisol Awakening Response: Regulation and Functional Significance. Endocrine Reviews. 2025;46:43–77. https://academic.oup.com/edrv/article/46/1/43/7739741

3. Rodriguez ACI, Epel ES, White ML, Standen EC, Seckl JR, Tomiyama AJ. Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review. Psychoneuroendocrinology. 2015;62:301–318. https://pubmed.ncbi.nlm.nih.gov/26356039/

4. Nieman LK, Biller BMK, Findling JW, et al. The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. https://www.endocrine.org/clinical-practice-guidelines/diagnosis-of-cushing-syndrome

5. Cadegiani FA, Kater CE. Adrenal fatigue does not exist: a systematic review. BMC Endocrine Disorders. 2016;16:48. https://pubmed.ncbi.nlm.nih.gov/27557747/

6. Endocrine Society. Adrenal Fatigue. https://www.endocrine.org/patient-engagement/endocrine-library/adrenal-fatigue

7. Akturk HK, Chindris AM, Hines JM, Singh RJ, Bernet VJ. Over-the-Counter “Adrenal Support” Supplements Contain Thyroid and Steroid-Based Adrenal Hormones. Mayo Clinic Proceedings. 2018;93:284–290. https://pubmed.ncbi.nlm.nih.gov/29502560/

8. Bachour G, et al. Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12242034/

---

This article discusses endocrine physiology and population-level evidence. Suspected Cushing syndrome or adrenal insufficiency requires clinical evaluation.